Logo image of BYM

BLACKROCK MUNI INC QLTY (BYM) Stock Price, Quote, News and Overview

NYSE:BYM - New York Stock Exchange, Inc. - US0924791041 - Currency: USD

10.38  +0.01 (+0.1%)

Fundamental Rating

2

Overall BYM gets a fundamental rating of 2 out of 10. We evaluated BYM against 0 industry peers in the Unkown industry. BYM has a bad profitability rating. Also its financial health evaluation is rather negative. BYM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BYM was profitable.
BYM had a negative operating cash flow in the past year.
BYM had positive earnings in 4 of the past 5 years.
BYM had a positive operating cash flow in each of the past 5 years.
BYM Yearly Net Income VS EBIT VS OCF VS FCFBYM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

Industry RankSector Rank
ROA 0.98%
ROE 1.47%
ROIC 2.06%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYM Yearly ROA, ROE, ROICBYM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

BYM's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of BYM has declined.
In the last couple of years the Gross Margin of BYM has declined.
Industry RankSector Rank
OM 58.14%
PM (TTM) 22.14%
GM 57.36%
OM growth 3Y-8.5%
OM growth 5Y-4.84%
PM growth 3Y8.86%
PM growth 5Y60.23%
GM growth 3Y-6.55%
GM growth 5Y-3.66%
BYM Yearly Profit, Operating, Gross MarginsBYM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1

2. Health

2.1 Basic Checks

There is no outstanding debt for BYM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BYM Yearly Shares OutstandingBYM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
BYM Yearly Total Debt VS Total AssetsBYM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that BYM is in the distress zone and has some risk of bankruptcy.
BYM has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 1.02
ROIC/WACCN/A
WACCN/A
BYM Yearly LT Debt VS Equity VS FCFBYM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

BYM has a Current Ratio of 1.00. This is a bad value and indicates that BYM is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 1.00 indicates that BYM may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
BYM Yearly Current Assets VS Current LiabilitesBYM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2

3. Growth

3.1 Past

BYM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.15%, which is quite impressive.
BYM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 58.49% yearly.
Looking at the last year, BYM shows a decrease in Revenue. The Revenue has decreased by -3.29% in the last year.
Measured over the past years, BYM shows a decrease in Revenue. The Revenue has been decreasing by -2.82% on average per year.
EPS 1Y (TTM)46.15%
EPS 3Y5.98%
EPS 5Y58.49%
EPS Q2Q%-110.71%
Revenue 1Y (TTM)-3.29%
Revenue growth 3Y-3.52%
Revenue growth 5Y-2.82%
Sales Q2Q%-3.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BYM Yearly Revenue VS EstimatesBYM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 54.63, the valuation of BYM can be described as expensive.
BYM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.30.
Industry RankSector Rank
PE 54.63
Fwd PE N/A
BYM Price Earnings VS Forward Price EarningsBYM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYM Per share dataBYM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.93
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.74%, BYM is a good candidate for dividend investing.
BYM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 5.74%

5.2 History

The dividend of BYM decreases each year by -3.58%.
BYM has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BYM decreased recently.
Dividend Growth(5Y)-3.58%
Div Incr Years1
Div Non Decr Years1
BYM Yearly Dividends per shareBYM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

349.28% of the earnings are spent on dividend by BYM. This is not a sustainable payout ratio.
DP349.28%
EPS Next 2YN/A
EPS Next 3YN/A
BYM Yearly Income VS Free CF VS DividendBYM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
BYM Dividend Payout.BYM Dividend Payout, showing the Payout Ratio.BYM Dividend Payout.PayoutRetained Earnings

BLACKROCK MUNI INC QLTY

NYSE:BYM (6/6/2025, 4:10:02 PM)

10.38

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)04-11 2023-04-11
Earnings (Next)N/A N/A
Inst Owners32.01%
Inst Owner Change1.78%
Ins Owners0%
Ins Owner Change0%
Market Cap268.84M
Analysts0
Price TargetN/A
Short Float %0.02%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 5.74%
Yearly Dividend0.57
Dividend Growth(5Y)-3.58%
DP349.28%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-15 2025-05-15 (0.0555)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 54.63
Fwd PE N/A
P/S 12.22
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)0.19
EY1.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.85
BVpS12.78
TBVpS12.78
PEG (NY)N/A
PEG (5Y)0.93
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 1.47%
ROCE 2.61%
ROIC 2.06%
ROICexc 2.06%
ROICexgc 2.06%
OM 58.14%
PM (TTM) 22.14%
GM 57.36%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.5%
OM growth 5Y-4.84%
PM growth 3Y8.86%
PM growth 5Y60.23%
GM growth 3Y-6.55%
GM growth 5Y-3.66%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.86
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 1.02
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.15%
EPS 3Y5.98%
EPS 5Y58.49%
EPS Q2Q%-110.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.29%
Revenue growth 3Y-3.52%
Revenue growth 5Y-2.82%
Sales Q2Q%-3.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.04%
EBIT growth 3Y-11.72%
EBIT growth 5Y-7.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.97%
FCF growth 3Y42.84%
FCF growth 5Y36.6%
OCF growth 1Y-102.97%
OCF growth 3Y42.84%
OCF growth 5Y36.6%